| Released | Contributor | Author | Title | Pages | Price |
| 17-Dec-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Industry Report for BIOTECHNOLOGY | 18 |
$49 |
| 17-Dec-2009 | Plunkett Research, Ltd. | Jack W. Plunkett | Biotechnology & Genetics Industry Market Research and Competitive Analysis 2010 | 569 |
$299 |
| 17-Dec-2009 | Plunkett Research, Ltd. | Jack W. Plunkett | Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary) | 71 |
$199 |
| 15-Dec-2009 | EconomicInvestor |
N/A
| "The Economy Matters" Report for CXM: the economy's impact on CXM's price and risk, featuring the powerful EconomicInvestor Star Rating | 6 |
$15 |
| 14-Dec-2009 | Reuters Investment Profile |
N/A
| Cardium Therapeutics Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. | 12 |
$20 |
| 11-Dec-2009 | Pechala's Reports | Lubomir Pechala | CARDIUM THERAPEUTICS INC (CXM=US) 2-weeks forecast | 1 |
$10 |
| 11-Dec-2009 | Pechala's Reports | Frantisek Pechala | CARDIUM THERAPEUTICS INC (CXM=US) 12-months forecast | 1 |
$15 |
| 10-Dec-2009 | Ford Investor Services, Inc. |
N/A
| Industry Value Graph: ADLS , CXM , INHX , THLD -- DRUGS | 3 |
$4 |
| 10-Dec-2009 | Ford Investor Services, Inc. |
N/A
| Value Graph: CARDIUM THERA -- CXM | 1 |
$4 |
0.05% Nasdaq 
1.06%
Research Reports
